These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 33684427)

  • 1. Fecal Mycobiota Combined With Host Immune Factors Distinguish Clostridioides difficile Infection From Asymptomatic Carriage.
    Cao Y; Wang L; Ke S; Villafuerte Gálvez JA; Pollock NR; Barrett C; Sprague R; Daugherty K; Xu H; Lin Q; Yao J; Chen Y; Kelly CP; Liu YY; Chen X
    Gastroenterology; 2021 Jun; 160(7):2328-2339.e6. PubMed ID: 33684427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of Intestinal Mycobiota of Patients with Clostridioides difficile Infection among a Prospective Inpatient Cohort.
    Cao Y; Wang L; Ke S; Kelly CP; Pollock NR; Villafuerte Gálvez JA; Daugherty K; Xu H; Yao J; Chen Y; Liu YY; Chen X
    Microbiol Spectr; 2022 Aug; 10(4):e0136222. PubMed ID: 35867408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrating gut microbiome and host immune markers to understand the pathogenesis of
    Ke S; Pollock NR; Wang XW; Chen X; Daugherty K; Lin Q; Xu H; Garey KW; Gonzales-Luna AJ; Kelly CP; Liu YY
    Gut Microbes; 2021; 13(1):1-18. PubMed ID: 34132169
    [No Abstract]   [Full Text] [Related]  

  • 4. Gut microbiome and mycobiome in inflammatory bowel disease patients with
    Yu S; Ge X; Xu H; Tan B; Tian B; Shi Y; Dai Y; Li Y; Hu S; Qian J
    Front Cell Infect Microbiol; 2023; 13():1129043. PubMed ID: 36814443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insight into alteration of gut microbiota in Clostridium difficile infection and asymptomatic C. difficile colonization.
    Zhang L; Dong D; Jiang C; Li Z; Wang X; Peng Y
    Anaerobe; 2015 Aug; 34():1-7. PubMed ID: 25817005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the gut microbiome of patients with
    Vázquez-Cuesta S; Villar L; García NL; Fernández AI; Olmedo M; Alcalá L; Marín M; Muñoz P; Bouza E; Reigadas E
    Front Cell Infect Microbiol; 2023; 13():1130701. PubMed ID: 37124040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated Meta-omics Reveals a Fungus-Associated Bacteriome and Distinct Functional Pathways in Clostridioides difficile Infection.
    Stewart DB; Wright JR; Fowler M; McLimans CJ; Tokarev V; Amaniera I; Baker O; Wong HT; Brabec J; Drucker R; Lamendella R
    mSphere; 2019 Aug; 4(4):. PubMed ID: 31462412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Environmental shedding of toxigenic Clostridioides difficile by asymptomatic carriers: A prospective observational study.
    Gilboa M; Houri-Levi E; Cohen C; Tal I; Rubin C; Feld-Simon O; Brom A; Eden-Friedman Y; Segal S; Rahav G; Regev-Yochay G;
    Clin Microbiol Infect; 2020 Aug; 26(8):1052-1057. PubMed ID: 31904567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Host Immune Markers Distinguish Clostridioides difficile Infection From Asymptomatic Carriage and Non-C. difficile Diarrhea.
    Kelly CP; Chen X; Williams D; Xu H; Cuddemi CA; Daugherty K; Barrett C; Miller M; Foussadier A; Lantz A; Banz A; Pollock NR
    Clin Infect Dis; 2020 Mar; 70(6):1083-1093. PubMed ID: 31211839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fungal and bacterial gut microbiota differ between
    Henderickx JGE; Crobach MJT; Terveer EM; Smits WK; Kuijper EJ; Zwittink RD
    Microbiome Res Rep; 2024; 3(1):8. PubMed ID: 38455084
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of Clostridioides difficile Stool Toxin Concentrations in Adults With Symptomatic Infection and Asymptomatic Carriage Using an Ultrasensitive Quantitative Immunoassay.
    Pollock NR; Banz A; Chen X; Williams D; Xu H; Cuddemi CA; Cui AX; Perrotta M; Alhassan E; Riou B; Lantz A; Miller MA; Kelly CP
    Clin Infect Dis; 2019 Jan; 68(1):78-86. PubMed ID: 29788296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Host Factors Associated with Gut Mycobiome Structure.
    Szóstak N; Handschuh L; Samelak-Czajka A; Tomela K; Schmidt M; Pruss Ł; Milanowska-Zabel K; Kozlowski P; Philips A
    mSystems; 2023 Apr; 8(2):e0098622. PubMed ID: 36786595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbiota restoration reduces antibiotic-resistant bacteria gut colonization in patients with recurrent Clostridioides difficile infection from the open-label PUNCH CD study.
    Langdon A; Schwartz DJ; Bulow C; Sun X; Hink T; Reske KA; Jones C; Burnham CD; Dubberke ER; Dantas G;
    Genome Med; 2021 Feb; 13(1):28. PubMed ID: 33593430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early gut mycobiota and mother-offspring transfer.
    Schei K; Avershina E; Øien T; Rudi K; Follestad T; Salamati S; Ødegård RA
    Microbiome; 2017 Aug; 5(1):107. PubMed ID: 28837002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Significance of Toxigenic Clostridioides difficile Growth in Stool Cultures during the Era of Nonculture Methods for the Diagnosis of C. difficile Infection.
    Lee CC; Lee JC; Chiu CW; Tsai PJ; Ko WC; Hung YP
    Microbiol Spectr; 2021 Oct; 9(2):e0079921. PubMed ID: 34668727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative characterization of Clostridioides difficile population in the gut microbiome of patients with C. difficile infection and their association with clinical factors.
    Kim J; Cho Y; Seo MR; Bae MH; Kim B; Rho M; Pai H
    Sci Rep; 2020 Oct; 10(1):17608. PubMed ID: 33077744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Dose Intramuscular Vitamin D3 Supplementation Impacts the Gut Microbiota of Patients With
    Lee SH; Park HK; Kang CD; Choi DH; Park SC; Park JM; Nam SJ; Chae GB; Lee KY; Cho H; Lee SJ
    Front Cell Infect Microbiol; 2022; 12():904987. PubMed ID: 35774395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Gut Bacterial Community Potentiates Clostridioides difficile Infection Severity.
    Lesniak NA; Schubert AM; Flynn KJ; Leslie JL; Sinani H; Bergin IL; Young VB; Schloss PD
    mBio; 2022 Aug; 13(4):e0118322. PubMed ID: 35856563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and risk factors for asymptomatic Clostridium difficile carriage.
    Alasmari F; Seiler SM; Hink T; Burnham CA; Dubberke ER
    Clin Infect Dis; 2014 Jul; 59(2):216-22. PubMed ID: 24755858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disordered Intestinal Microbial Communities During
    Chen Y; Lv T; Yan D; Zheng L; Zheng B; Wang J; Gu S; Li L
    Front Cell Infect Microbiol; 2022; 12():825189. PubMed ID: 35433508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.